Características de la resistencia antimicrobiana de una colección clínica de Streptococcus pyogenes

Rodríguez, Romeo S; Calderón Jaimes, Ernesto; Gómez Barreto, Demóstenes; Espinosa de los Monteros, Luz Elena.
Salud pública Méx ; 42(3): 226-9, mayo-jun. 2000. tab
Artigo em Espanhol | LILACS | ID: lil-280462

Documentos relacionados

  1. Recovery of cefazolin and clindamycin in in vitro pediatric CPB systems.
  2. Safety and Pharmacokinetic Characterization of Nacubactam, a Novel ß-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers.
  3. Pharmacokinetics of intravenous clindamycin phosphate in captive Bennett's wallabies (Macropus rufogriseus).
  4. Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.
  5. [Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia].
  6. [Blood and respiratory diffusion of antibiotics. A critical analysis of predictive parameters for clinical effectiveness].
  7. Bioavailability testing of a newly developed clindamycin oral suspension in a pediatric porcine model.
  8. Relation of Streptococcus Pyogenes tonsillitis isolate to antimicrobial agents and its infection treatment.
  9. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic.
  10. Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections.